181 related articles for article (PubMed ID: 28299656)
1. Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis.
Liau WS; Ngoc PC; Sanda T
Adv Exp Med Biol; 2017; 962():139-147. PubMed ID: 28299656
[TBL] [Abstract][Full Text] [Related]
2. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell enhancer: a powerful tool in stem cell biology.
Koh CP; Ng CE; Nah GS; Wang CQ; Tergaonkar V; Matsumura T; Yokomizo T; Suda T; Osato M
Histol Histopathol; 2015 Jun; 30(6):661-72. PubMed ID: 25574754
[TBL] [Abstract][Full Text] [Related]
4. A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells.
Ng CE; Yokomizo T; Yamashita N; Cirovic B; Jin H; Wen Z; Ito Y; Osato M
Stem Cells; 2010 Oct; 28(10):1869-81. PubMed ID: 20799333
[TBL] [Abstract][Full Text] [Related]
5. HOXB4 Promotes Hemogenic Endothelium Formation without Perturbing Endothelial Cell Development.
Teichweyde N; Kasperidus L; Carotta S; Kouskoff V; Lacaud G; Horn PA; Heinrichs S; Klump H
Stem Cell Reports; 2018 Mar; 10(3):875-889. PubMed ID: 29456178
[TBL] [Abstract][Full Text] [Related]
6. Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1.
Majumder A; Syed KM; Joseph S; Scambler PJ; Dutta D
J Biol Chem; 2015 May; 290(21):13053-63. PubMed ID: 25847244
[TBL] [Abstract][Full Text] [Related]
7. A Runx1-Smad6 rheostat controls Runx1 activity during embryonic hematopoiesis.
Knezevic K; Bee T; Wilson NK; Janes ME; Kinston S; Polderdijk S; Kolb-Kokocinski A; Ottersbach K; Pencovich N; Groner Y; de Bruijn M; Göttgens B; Pimanda JE
Mol Cell Biol; 2011 Jul; 31(14):2817-26. PubMed ID: 21576367
[TBL] [Abstract][Full Text] [Related]
8. A DNA Contact Map for the Mouse Runx1 Gene Identifies Novel Haematopoietic Enhancers.
Marsman J; Thomas A; Osato M; O'Sullivan JM; Horsfield JA
Sci Rep; 2017 Oct; 7(1):13347. PubMed ID: 29042628
[TBL] [Abstract][Full Text] [Related]
9. Mathematical model of a gene regulatory network reconciles effects of genetic perturbations on hematopoietic stem cell emergence.
Narula J; Williams CJ; Tiwari A; Marks-Bluth J; Pimanda JE; Igoshin OA
Dev Biol; 2013 Jul; 379(2):258-69. PubMed ID: 23623899
[TBL] [Abstract][Full Text] [Related]
10. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.
Nottingham WT; Jarratt A; Burgess M; Speck CL; Cheng JF; Prabhakar S; Rubin EM; Li PS; Sloane-Stanley J; Kong-A-San J; de Bruijn MF
Blood; 2007 Dec; 110(13):4188-97. PubMed ID: 17823307
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs.
Subramanian S; Thoms JAI; Huang Y; Cornejo-Páramo P; Koch FC; Jacquelin S; Shen S; Song E; Joshi S; Brownlee C; Woll PS; Chacon-Fajardo D; Beck D; Curtis DJ; Yehson K; Antonenas V; O'Brien T; Trickett A; Powell JA; Lewis ID; Pitson SM; Gandhi MK; Lane SW; Vafaee F; Wong ES; Göttgens B; Alinejad-Rokny H; Wong JWH; Pimanda JE
Blood; 2023 Oct; 142(17):1448-1462. PubMed ID: 37595278
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
[TBL] [Abstract][Full Text] [Related]
13. The Role of TAL1 in Hematopoiesis and Leukemogenesis.
Vagapova ER; Spirin PV; Lebedev TD; Prassolov VS
Acta Naturae; 2018; 10(1):15-23. PubMed ID: 29713515
[TBL] [Abstract][Full Text] [Related]
14. Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells.
Challen GA; Goodell MA
Exp Hematol; 2010 May; 38(5):403-16. PubMed ID: 20206228
[TBL] [Abstract][Full Text] [Related]
15. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.
Jacob B; Osato M; Yamashita N; Wang CQ; Taniuchi I; Littman DR; Asou N; Ito Y
Blood; 2010 Feb; 115(8):1610-20. PubMed ID: 20008790
[TBL] [Abstract][Full Text] [Related]
16. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
Kumano K; Kurokawa M
J Cell Physiol; 2010 Feb; 222(2):282-5. PubMed ID: 19847803
[TBL] [Abstract][Full Text] [Related]
17. Redundant mechanisms driven independently by RUNX1 and GATA2 for hematopoietic development.
Bresciani E; Carrington B; Yu K; Kim EM; Zhen T; Guzman VS; Broadbridge E; Bishop K; Kirby M; Harper U; Wincovitch S; Dell'Orso S; Sartorelli V; Sood R; Liu P
Blood Adv; 2021 Dec; 5(23):4949-4962. PubMed ID: 34492681
[TBL] [Abstract][Full Text] [Related]
18. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
Hyde RK; Zhao L; Alemu L; Liu PP
Leukemia; 2015 Aug; 29(8):1771-8. PubMed ID: 25742748
[TBL] [Abstract][Full Text] [Related]
19. Increase of hematopoietic progenitor and suppression of endothelial gene expression by Runx1 expression during in vitro ES differentiation.
Sakai E; Kitajima K; Sato A; Nakano T
Exp Hematol; 2009 Mar; 37(3):334-45. PubMed ID: 19218012
[TBL] [Abstract][Full Text] [Related]
20. Taking the Leap: Runx1 in the Formation of Blood from Endothelium.
Tober J; Maijenburg MW; Speck NA
Curr Top Dev Biol; 2016; 118():113-62. PubMed ID: 27137656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
